GlassScriptPhysician profile
Sarah Maxey
NPI 1477118388
$3,548.23
in general payments reported to CMS, 2019-2025
9 companies · $43.36 in 2025
The $43.36 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $56.05 · 2024: $3,449 · 2025: $43.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $559 · Food and Beverage: $490.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $558.51 |
| Food and Beverage | $489.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,245.48 | 2024 | |
| Astellas Pharma US INC | $124.64 | 2024 | Veozah |
| Hologic Sales and Service, LLC | $40.01 | 2024-2025 | Novasure |
| Takeda Pharmaceuticals U.S.A., INC. | $32.67 | 2023 | Gattex |
| Biogen, INC. | $27.61 | 2025 | Zurzuvae |
| Astrazeneca Pharmaceuticals LP | $23.38 | 2023 | |
| Vivus LLC | $22.46 | 2024 | Qsymia |
| Coopersurgical, INC. | $18.03 | 2024 | Paragard T 380a |
| Organon LLC | $13.95 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Maxey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.